Edofoam ER 300 Tablet contains Etodolac 300mg, an extended-release NSAID designed for the management of pain and inflammation in conditions such as osteoarthritis, rheumatoid arthritis, and musculoskeletal disorders. Its formulation provides sustained relief over a prolonged period, reducing the need for frequent dosing.
The 300mg strength ensures effective analgesia and anti-inflammatory action while maintaining a favorable tolerability profile. It is ideal for patients requiring consistent pain control and improved mobility.
For hospitals, orthopedic clinics, and distributors, Edofoam ER 300 Tablet is a high-demand pain management product, widely prescribed in orthopedic departments, physiotherapy centers, and multispecialty hospitals. Regular use ensures steady orders and strong market presence.
Adding Edofoam ER 300 Tablet to your portfolio strengthens your pain management and orthopedic segment, creating opportunities in hospital procurement, pharmacy distribution, institutional orders, export markets, and third-party manufacturing. Its clinical reliability and patient-friendly extended-release profile make it a valuable addition for pharmaceutical distributors.+++